2019 In Cardiology: Apple Heart Study Lands; Icosapent Ethyl Gets FDA Nod for New...
Another year in the books, and there were some important news stories in cardiology this year. 2091 carried big news for a few drug therapies
E-Cigarettes Take a Dangerous Toll on Heart Health
Electronic cigarette (e-cigarette) use negatively impacts heart disease risk factors such as cholesterol, triglycerides and blood sugar levels, according to new research being presented...
Cardio Round-up: American Indians and AFib Risk; Benefits from Cardiac Rehab; and More
This week's edition features a look at heightened risk for atrial fibrillation in a Native American population, a study looking at the benefits of...
Evolocumab Well-tolerated as Add-on for Hypercholesterolemia Therapy
Evolocumab added to standard care for hypercholesterolemia was well-tolerated in a diverse patient population, a new analysis revealed.
Evolocumab and other anti-PCSK9 antibodies reduced adverse...
Cardio Round-up: Machine Learning Speeds Up MRI Assessment, and Much More
This week's round-up includes two pieces continuing to expand the views on how machine learning and artificial intelligence can affect cardiac care, as well...
Low-dose Inclisiran Linked with Reduced LDL Cholesterol
A infrequent dosing regimen of inclisiran could offer another therapeutic option for lowering low-density lipoprotein cholesterol (LDL-C).
The prespecified analysis and one-year follow up of...
Alirocumab Plus Statin Reduces Death after ACS: Analysis
A recent analysis of the results of the ODYSSEY OUTCOMES trail suggests that the PCSK9 inhibitor alirocumab added to statin therapy in patients with...
